|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Muto T, Bussey HJ and Morson BC: The
evolution of cancer of the colon and rectum. Cancer. 36:2251–2270.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shinya H and Wolff WI: Morphology,
anatomic distribution and cancer potential of colonic polyps. Ann
Surg. 190:679–683. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Masuda T, Hayashi N, Kuroda Y, Ito S,
Eguchi H and Mimori K: MicroRNAs as biomarkers in colorectal
cancer. Cancers (Basel). 9:1242017. View Article : Google Scholar
|
|
5
|
Zhan C, Yan L, Wang L, Jiang W, Zhang Y,
Xi J, Jin Y, Chen L, Shi Y, Lin Z and Wang Q: Landscape of
expression profiles in esophageal carcinoma by the cancer genome
Atlas data. Dis Esophagus. 29:920–928. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedlander MR, Chen W, Adamidi C,
Maaskola J, Einspanier R, Knespel S and Rajewsky N: Discovering
microRNAs from deep sequencing data using miRDeep. Nat Biotechnol.
26:407–415. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. Aug 12–2015.doi: 10.7554/eLife.05005. View Article : Google Scholar
|
|
8
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
The Gene Ontology Consortium: Expansion of
the Gene Ontology knowledgebase and resources. Nucleic Acids Res.
45:D331–D338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45:D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan L, Zhan C, Wu J and Wang S: Expression
profile analysis of head and neck squamous cell carcinomas using
data from The Cancer Genome Atlas. Mol Med Rep. 13:4259–4265. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Slattery ML, Herrick JS, Pellatt DF,
Stevens JR, Mullany LE, Wolff E, Hoffman MD, Samowitz WS and Wolff
RK: MicroRNA profiles in colorectal carcinomas, adenomas and normal
colonic mucosa: Variations in miRNA expression and disease
progression. Carcinogenesis. 37:245–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Raju GS, Chang DW, Lin SH, Chen Z
and Wu X: Global and targeted circulating microRNA profiling of
colorectal adenoma and colorectal cancer. Cancer. 124:785–796.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia L, Luo S, Ren X, Li Y, Hu J, Liu B,
Zhao L, Shan Y and Zhou H: miR-182 and miR-135b mediate the
tumorigenesis and invasiveness of colorectal cancer cells via
targeting ST6GALNAC2 and PI3K/AKT pathway. Dig Dis Sci.
62:3447–3459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y
and Jia L: Upregulation of microRNA-135b and microRNA-182 promotes
chemoresistance of colorectal cancer by targeting ST6GALNAC2 via
PI3K/AKT pathway. Mol Carcinog. 56:2669–2680. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yau TO, Wu CW, Dong Y, Tang CM, Ng SS,
Chan FK, Sung JJ and Yu J: microRNA-221 and microRNA-18a
identification in stool as potential biomarkers for the
non-invasive diagnosis of colorectal carcinoma. Br J Cancer.
111:1765–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Inoue A, Yamamoto H, Uemura M, Nishimura
J, Hata T, Takemasa I, Ikenaga M, Ikeda M, Murata K, Mizushima T,
et al: MicroRNA-29b is a novel prognostic marker in colorectal
cancer. Ann Surg Oncol. 22 (Suppl 3):S1410–S1418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang B, Li W, Liu H, Yang L, Liao Q, Cui
S, Wang H and Zhao L: miR-29b suppresses tumor growth and
metastasis in colorectal cancer via downregulating Tiam1 expression
and inhibiting epithelial-mesenchymal transition. Cell Death Dis.
5:e13352014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang JY, Huang JC, Chen G and Wei DM:
Expression level and potential target pathways of miR-1-3p in
colorectal carcinoma based on 645 cases from 9 microarray datasets.
Mol Med Rep. 17:5013–5020. 2018.PubMed/NCBI
|
|
21
|
Xu W, Zhang Z, Zou K, Cheng Y, Yang M,
Chen H, Wang H, Zhao J, Chen P, He L, et al: MiR-1 suppresses tumor
cell proliferation in colorectal cancer by inhibition of
Smad3-mediated tumor glycolysis. Cell Death Dis. 8:e27612017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu L, Zhang Y, Wang H, Zhang G, Ding Y and
Zhao L: Tumor suppressor miR-1 restrains epithelial-mesenchymal
transition and metastasis of colorectal carcinoma via the MAPK and
PI3K/AKT pathway. J Transl Med. 12:2442014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun K, Deng HJ, Lei ST, Dong JQ and Li GX:
miRNA-338-3p suppresses cell growth of human colorectal carcinoma
by targeting smoothened. World J Gastroenterol. 19:2197–2207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun K, Su G, Deng H, Dong J, Lei S and Li
G: Relationship between miRNA-338-3p expression and progression and
prognosis of human colorectal carcinoma. Chin Med J (Engl).
127:1884–1890. 2014.PubMed/NCBI
|
|
25
|
Liu M, Yin K, Guo X, Feng H, Yuan M, Liu
Y, Zhang J, Guo B, Wang C, Zhou G, et al: Diphthamide biosynthesis
1 is a novel oncogene in colorectal cancer cells and is regulated
by MiR-218-5p. Cell Physiol Biochem. 44:505–514. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ilm K, Fuchs S, Mudduluru G and Stein U:
MACC1 is post-transcriptionally regulated by miR-218 in colorectal
cancer. Oncotarget. 7:53443–53458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li PL, Zhang X, Wang LL, Du LT, Yang YM,
Li J and Wang CX: MicroRNA-218 is a prognostic indicator in
colorectal cancer and enhances 5-fluorouracil-induced apoptosis by
targeting BIRC5. Carcinogenesis. 36:1484–1493. 2015.PubMed/NCBI
|
|
28
|
Zhang X, Shi H, Tang H, Fang Z, Wang J and
Cui S: miR-218 inhibits the invasion and migration of colon cancer
cells by targeting the PI3K/Akt/mTOR signaling pathway. Int J Mol
Med. 35:1301–1308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bogaert J and Prenen H: Molecular genetics
of colorectal cancer. Ann Gastroenterol. 27:9–14. 2014.PubMed/NCBI
|
